Therapeutic Cloning

Therapeutic Cloning, also known as somatic cell nuclear transfer (SCNT), is a cutting-edge biotechnological approach with potential applications in regenerative medicine. Unlike reproductive cloning, which aims to create genetically identical organisms, therapeutic cloning focuses on generating embryonic stem cells for therapeutic purposes. The process involves transferring the nucleus of a somatic cell, typically a skin cell, into an enucleated egg cell, creating a cloned embryo. This embryo is then stimulated to divide and develop, eventually forming a blastocyst from which embryonic stem cells can be harvested. These stem cells have the remarkable ability to differentiate into various cell types, offering the potential to replace damaged or diseased tissues. Therapeutic cloning holds promise for treating degenerative conditions, spinal cord injuries, and diseases such as Parkinson's and diabetes. While still in the experimental stage, therapeutic cloning has sparked ethical debates due to concerns about embryo destruction and the creation of human embryos solely for research purposes. However, ongoing research continues to refine the techniques involved in therapeutic cloning, addressing ethical concerns and moving toward its potential use in personalized medicine and regenerative therapies.